DOI QR코드

DOI QR Code

Correction to "Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?"

  • Hee Sun Baek (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Min Hyun Cho (Department of Pediatrics, School of Medicine, Kyungpook National University)
  • Published : 2026.02.28

Abstract

Keywords

References

  1. Baek HS, Cho MH. Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease? Child Kidney Dis 2023;27:76-8. https://doi.org/10.3339/ckd.23.021